Insider trade

Alzamend Neuro (ALZN): Director sold ~$28K

Milton C Iii Ault, Director at Alzamend Neuro, sold ~$28K of Alzamend Neuro shares.

~$28K
Approx. value · 9,621 sh @ $2.93
83K
Holds after · shares reported
Traded
Jul 24, 2025
Filed
Jul 26, 2025

What stands out in this filing

  • The sale was 10.4% of the shares this insider held before it; the filing reports 82,552 shares, held indirectly afterwards.
  • 9,621 shares at an average of $2.93 each, as reported on the form.
  • No footnote on the form refers to a pre-arranged trading plan (Rule 10b5-1).

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jul 23, 2025InsiderDirector sold ~$176K of ALZN shares in the open market
  2. Jul 24, 2025 · this disclosureInsiderDirector sold ~$28K of ALZN shares in the open market

What came next

  1. Jul 25, 2025InsiderDirector sold ~$106K of ALZN shares in the open market
  2. Jul 28, 2025InsiderDirector sold ~$22K of ALZN shares in the open market
  3. Jul 30, 2025InsiderDirector sold ~$74K of ALZN shares in the open market
  4. Jul 31, 2025InsiderDirector sold ~$222K of ALZN shares in the open market
  5. Sep 17, 2025InsiderDirector sold ~$5.2K of ALZN shares in the open market
  6. Sep 18, 2025InsiderDirector sold ~$51K of ALZN shares in the open market
  7. Sep 19, 2025InsiderDirector sold ~$181K of ALZN shares in the open market
  8. Sep 23, 2025InsiderDirector sold ~$103K of ALZN shares in the open market
  9. Sep 24, 2025InsiderDirector sold ~$90K of ALZN shares in the open market
  10. Sep 25, 2025Company filing · Form 8-K · Unregistered sharesSold new shares without registering them
  11. Sep 25, 2025InsiderDirector sold ~$34K of ALZN shares in the open market
  12. Sep 26, 2025InsiderDirector sold ~$87K of ALZN shares in the open market
  13. Sep 29, 2025InsiderDirector sold ~$88K of ALZN shares in the open market
  14. Sep 30, 2025InsiderDirector sold ~$8.3K of ALZN shares in the open market
  15. Oct 6, 2025InsiderDirector sold ~$201K of ALZN shares in the open market
  16. Oct 7, 2025InsiderDirector sold ~$143K of ALZN shares in the open market
  17. Oct 8, 2025InsiderDirector sold ~$247K of ALZN shares in the open market
  18. Oct 9, 2025Company filing · Form 8-K · Unregistered sharesSold new shares without registering them
  19. Oct 9, 2025InsiderDirector sold ~$47K of ALZN shares in the open market
  20. Oct 14, 2025Company filing · Form 8-K · Bylaws or charterChanged its bylaws, charter or fiscal year
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Alzamend Neuro

For Alzamend Neuro, OQRO holds 3 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ALZN page.

Other recent filings by Milton C Iii Ault, Director

The full history of Milton C Iii Ault, Director is on the profile page.

How this filing works

Explore the data

Common questions

Which Alzamend Neuro (ALZN) insider traded, and how much?

Milton C Iii Ault, Director at Alzamend Neuro, sold ~$28K of Alzamend Neuro shares. 9,621 shares at $2.93.

When did it happen, and when was it made public?

Traded: Jul 24, 2025. Filed: Jul 26, 2025. That is 2 days between the two dates.

What stands out in this filing?

The sale was 10.4% of the shares this insider held before it; the filing reports 82,552 shares, held indirectly afterwards. 9,621 shares at an average of $2.93 each, as reported on the form. No footnote on the form refers to a pre-arranged trading plan (Rule 10b5-1).

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Alzamend Neuro recently?

For Alzamend Neuro, OQRO holds 3 insider filings (SEC Form 4 or Form 144) dated in the last 90 days. They are listed on the ALZN page.

Does this mean ALZN stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Alzamend Neuro

Everything OQRO holds on this company is on its ALZN page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data